Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.
BIO is the world’s largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
The UK Pavilion will be organised by the Office for Life Sciences (OLS). Pavilion exhibitors are granted access to the partnering system, with limited location access. It is recommended that one delegate uses the exhibitor partnering access, and a second delegate purchases a Premier pass here.
Since 2021, the Swiss Biotech Day has seen remarkable growth and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2025 it attracted more than 3,000 participants from 49 countries, including 25 international delegations.
*One Nucleus members receive a 12% discount via BioPartner, please email [email protected] for more information.
Prime.io Ltd helps antibody and drug target validation teams to generate high-quality knock-in and knock-out cell models—fast. Powered by our proprietary AI designed CRISPR platform (commercial licence available), we deliver:
• 3x higher knock-in efficiency than conventional spCas9 in pool and single cancer/iPSC cell derived clone
• Up to 97% knock-out efficiency in single cancer/iPSC cell derived clone
• Reduced off-target activity and immunogenicity
• NGS-validated single-cell clones
At Cancer Research UK, we exist to beat cancer.
We have an exciting opportunity for an experienced Scientist to join our Discovery Biology function at Cancer Research Horizons. Sitting within the Bioscience department, the Discovery Biology group focuses on defining the key biological insights needed to advance drug discovery projects. The team leads biomarker discovery, investigates disease pathways and drug mechanisms of action, and provides experimental evidence to help guide early clinical strategy.
bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.
Pharmaron is a global CRO helping pharma and biotech companies bring new therapies to life. With over 21,000 employees across 23 sites in the UK, US and China, we support drug discovery through to manufacturing with fully integrated, high-quality services.
We’re proud of the impact we make—last year alone we supported over 780 discovery projects, 1,000+ CMC programmes and more than 1,000 clinical trials. Our teams work across small molecules, biologics and gene therapies, supporting over 3,000 global customers.
We Are Looking For
At AstraZeneca, we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We’re passionate about the potential of science to address the unmet needs of patients around the world. We commit to those areas where we believe we can really change the course of medicine and bring big new ideas to life.
Are you ready to work on one of the most exciting pipelines in the Oncology industry?